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Abstract
Head dysgenesis is a major cause of fetal demise and craniofacial malformation. Although mutations in genes of the
head ontogenetic program have been reported, many cases remain unexplained. Head dysgenesis has also been
related to trisomy or amplification of the chromosomal region overlapping the CDX2 homeobox gene, a master
element of the trunk ontogenetic program. Hence, we investigated the repercussion on head morphogenesis of the
imbalance between the head and trunk ontogenetic programs, by means of ectopic rostral expression of CDX2 at
gastrulation. This caused severe malformations affecting the forebrain and optic structures, and also the frontonasal
process associated with defects in neural crest cells colonization. These malformations are the result of the
downregulation of genes of the head program together with the abnormal induction of trunk program genes.
Together, these data indicate that the imbalance between the anterior and posterior ontogenetic programs in
embryos is a new possible cause of head dysgenesis during human development, linked to defects in setting up
anterior neuroectodermal structures.
Introduction
Head dysgenesis during embryonic development is a
major cause of fetal demise occurring in ~1/250 con-
ceptuses1. It covers a large spectrum of craniofacial and
brain malformations and involves mutations in genes of
the anterior ontogenetic program as well as environ-
mental conditions. Yet, a great number of cases still
remain unexplained2. During embryogenesis, the head is
the first body part to form around gastrulation from
resident anterior epiblast cells3,4. Unlike the head, the
trunk is newly built by progressive posterior addition of
tissue from the posterior epiblast through the primitive
streak to get the three germ layers5. The posterior onto-
genetic program notably differs from the head program by
the involvement of an intricate network of homeobox
transcription factor genes including the caudal-related
paraHox genes Cdx1/2/4, the POU-homeobox gene Oct4
and the genes of the four Hox clusters6,7. Cdx1/2/4, whose
nested expression is limited rostrally in rhombomere 3,
are crucial for maintaining the pool of posterior elonga-
tion progenitors, so that Cdx-null murine embryos fail
developing body structures beyond the occiput8. Oct4
sustains progenitor pluripotency9, and Hox genes10,
together with Cdx1/211,12, provide the growing posterior
tissues their anteroposterior (AP) positional information.
Hox clusters genes, limited anteriorly in rhombomere 213,
exhibit spatial and temporal colinearity6,7 under complex
regulatory mechanisms involving notably the CDX
factors14,15.
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Among the three CDX paralogues, CDX2, located on
human chromosome 13, is important not only for pos-
terior elongation and patterning at gastrulation but also
earlier in the trophectoderm16,17 and later in the gut18,19.
Noteworthy, although CDX2 is not normally expressed in
head progenitors, head dysgenesis has been frequently
associated with the trisomy of chromosome 13 (Patau
syndrome)20 or with partial trisomy of the long arm of this
chromosome including the region q12.2 that overlaps the
CDX2 locus21,22. The Patau syndrome is a rare and dra-
matic disease whose prevalence is estimated at 1:12,000 to
1:29,000 in newborns with a median survival time of
6–10 days23.
On this basis, the link between the amplification of the
locus containing the posterior ontogenetic gene, CDX2,
and the occurrence of rostral malformations led us to
investigate the repercussion on head morphogenesis of
disturbing the balance between anterior and posterior
developmental programs, by means of ectopically
expressing CDX2 rostrally at gastrulation.
Results
Head dysgenesis caused by rostral ectopic expression of
CDX2
Mice designed for inducible expression of the human
CDX2 homeobox gene, the RsCDX2mice, were generated
by inserting into the Ros26 locus the human CDX2 cDNA
preceded by a loxP-flanked transcriptional stop cassette
(Fig. 1A). Ectopic expression of the CDX2 protein ros-
trally to its anterior limit in rhombomere 3 was achieved
using these mice crossed with Sox2CreERT2 mice
expressing CreERT2 in the whole epiblast at gastrulation,
while the pregnant females received a single injection of
Tamoxifen at day 6.5 post-coitum. The procedure was
validated by demonstrating the rostral expression of
Tomato protein in RosaCAGtdTomato::Sox2CreERT2
embryos (Fig. 1Ba), mainly at the level of the neuroe-
pithelium, neural crest derived cells and ectoderm, but
not in the cephalic mesenchyme (Fig. 1Bb). It was then
successfully applied to RsCDX2::Sox2CreERT2 embryos to
trigger ectopic expression of CDX2 in these tissues, as
shown by whole-mount immunohistochemistry and
immunostaining on tissue sections (Fig. 1C) and by
RTqPCR (Fig. 1D). Although no macroscopic phenotype
was displayed in mutants before E9.5, head dysmor-
phology characterized by a flattened anterior aspect
appeared around E10.5, worsened at E12.5, and led to
profound deformities at E15.5 (Fig. 1E; Supplementary
Figure S1): the frontonasal process was missing leading to
exencephaly, eyes were absent or limited to rudimentary
structures and the maxillary branch of the first phar-
yngeal arch failed to merge axially. Half of the mutants
also exhibited preaxial forelimb polydactyly (Supple-
mentary Figure S1).
Rostral ectopic expression of CDX2 perturbs the anterior
ontogenetic program and induces elements of the
posterior program
Transcriptome analysis of the head of E10.5 control and
mutant RsCDX2::Sox2CreERT2 littermates identified 532
differentially-expressed genes (Supplementary Table S1)
falling into 3 categories by Principal Component Analysis
(Fig. 2A, B; Supplementary Table S2 sheet 1). Category 1
corresponded to the 143 genes downregulated in mutants
and functional annotation clustering revealed that it
organized into 3 clusters respectively associated with the
Gene Ontology (GO) terms Axon/Dendrite; Cerebral
cortex neuron differentiation/Negative regulation of
neuron differentiation; and Sequence-specific DNA
binding. Several of the downregulated genes encoding
DNA binding factors are crucial for head development
like Otx1 (brain and sensory organ development), Foxg1,
Nkx2.1 and Six3 (telencephalon formation), Tal2 (mid-
brain formation), Six2 (growth of the cranial base), Ascl1
and Myb (neuronal commitment and progenitor pro-
liferation), Nr2e1 (forebrain and retina stem cell deter-
mination), Six3, Six6, Eya4, Vax1 and Vsx2 (eye
morphogenesis), Tcf7L2 (radial migration of cortical
neurons), Fezf2 and Bcl11a (subcerebral neurons specifi-
cation), Helt (GABAergic neurogenesis), Rora (Purkinje
cells development), and Zbtb20 (hippocampal neuronal
determination). Thus, the head ontogenetic program is
largely perturbed following the rostral induction of CDX2
expression. Unlike the category 1, the categories 2 and 3
covered the 389 upregulated genes. Category 2 (364
genes) subdivides into 5 clusters associated with the GO
terms Extracellular matrix region; Anterior–posterior
patterning/Sequence-specific DNA binding/Regulation of
transcription; Collagen; and Wnt signaling. Category 3 (25
genes) presents the cluster with the highest enrichment
score, related to the GO terms Anterior-posterior pat-
terning/Sequence-specific DNA binding/Regulation of
transcription/Embryonic skeletal morphogenesis. To go
further into the characterization of the 389 genes upre-
gulated by rostral ectopic expression of CDX2, the list of
genes of the categories 2 and 3 was compared with two
other experimental conditions where the Cdx function is
altered14: the genes downregulated in E8 Cdx-null
embryos in which the trunk program is arrested, and the
genes upregulated in epiblast stem cells cultured with a
Wnt agonist plus Fgf8 to recapitulate the onset of the
posterior program including Cdx2 (Fig. 2C, D; Supple-
mentary Table S2 sheet 2). Several genes arose by pairwise
comparison while the 3 lists exhibited a set of 11 genes in
common. Remarkably, the genes identified in the pairwise
comparisons as well as the 11 genes in common in the 3
experimental conditions are related to the GO terms
Anterior-posterior patterning/DNA binding/Regulation
of transcription. This highlights that rostral CDX2
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induction not only perturbs the normal anterior ontoge-
netic program of the head, but it also turns on elements of
the posterior program normally active in the developing
trunk.
Ectopic CDX2 turns on the expression of all central Hox
clusters genes
Transcription factor genes represent 19.7% (105/532) of
the genes deregulated by ectopic expression of CDX2
(Supplementary Table S2 sheet 3). Their relevance is
supported by the significant enrichment in DNA binding
sites for 45 of them (42.9%; FDR < 0.02) in the −2000/+
50-bp promoters of the whole set of deregulated genes
(Fig. 3A). These 45 factors fall into 9 groups according to
their DNA binding domain. Homeobox genes, known to
be crucial in morphogenesis, represent 48 of the 105
deregulated transcription factor genes and correspond to
5 of the 9 groups identified by DNA binding sites
enrichment. Importantly, these homeobox genes include
the majority (24/39) of the genes of the four Hox clusters,
especially those involved in trunk patterning (Fig. 3B).
Indeed, while transcripts of the anterior genes Hoxa1,
−a2, −b1, and −b2 were already present in the head of
control embryos, consistent with their normal anterior
limit in the hindbrain, all the 17 central cluster genes from
position 3 to 9-10, also belonging to the set of 25 genes of
the category 3 in the Principal Component Analysis, were
unexpressed in the head of control embryos but turned on
in the mutants. More posterior Hox genes at positions
11–13, controlled by Gdf11 instead of Cdx in the trunk-
tail transition24, remained silent. Chromatin immuno-
precipitation (ChIP) targeting the Cdx2-binding site pre-
viously identified and functionally characterized upstream
of the Hoxa5 gene15,25 showed occupancy by the endo-
genous Cdx2 protein in the trunk but not in the head of
control E10.5 embryos, as expected; however, the CDX2
protein was actually bound to this site in the head of
RsCDX2::Sox2CreERT2 littermates (Fig. 3C), demonstrating
the direct interaction of CDX2 with the Hoxa5 promoter
when this gene becomes turned on in the head of mutant
embryos. Thus, ectopic expression of CDX2 is able to
switch on central Hox genes in the head, similar to what
happens during trunk morphogenesis.
Ectopic CDX2 perturbs cell fate and cell interactions
Histology was analyzed in mutants between E9.5 and
E15.5 and representative pictures of embryos at day 10.5
and 13.5 are illustrated in Fig. 4A, B. As shown at E13.5,
Fig. 1 Morphologic alterations caused by rostral ectopic expression of CDX2. A The RsCDX2 allele; SA: Splicing Acceptor site; GHpA:
polyadenylation site of the human Growth Hormone gene. Ba Tomato fluorescence emitted by E10.5 RosaCAGtdTomato::Sox2CreERT2 embryos exposed
to Tamoxifen at E6.5. The arrowhead points to the anterior limb bud. Bar: 500 µm. b Transversal sections in the telencephalon showing Tomato
fluorescence emission at the level of the neuroepithelium (asterisk), neural crest derived cells (closed circle) and ectoderm (arrow) but not in the
cephalic mesenchyme (open square). Bars: 50 µm. C Immunodetection of the CDX2 protein in whole-mount preparations of E9.5 control (ctrl) and
RsCDX2::Sox2CreERT2 (mutant) littermates, and in sections of E10.5 control and mutant embryos. Red and blue dotted lines mark head and tail,
respectively. Arrowheads show the endogenous Cdx2 in the gut endoderm. Bars: 500 µm. D Relative RNA levels by RTqPCR of the transcripts for
endogenous Cdx2 (open squares) and for the CDX2 transgene (black squares) in the head (H), trunk (Tr) and tail (Ta) of 3 mutant embryos at E10.5.
E Morphology of E10.5, E12.5 and E15.5 control and mutant embryos. Bars: 1 mm
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profound tissue disorganization occurred rostrally where
ectopic CDX2 was the highest in the neuroepithelium.
The shape of the diencephalon and third ventricle was
altered together with the atrophied structures of the tel-
encephalon and lateral ventricles; the choroid invagina-
tion was missing and eyes were absent or poorly formed.
Craniofacial structures were also missing. These altera-
tions connected with the reduced level or absence of
forebrain transcription factors, as shown by immunohis-
tochemistry at E10.5 for Nkx2.1 and Foxg1 in the tele-
ncephalon (Fig. 4) and even more pronounced at E13.5 for
Foxg1 in the lateral ventricles, Nkx2.1 in the medial
ganglionic eminence, Otx2 in the medial ganglionic
eminence and choroid plexus and Six3 in the dience-
phalon (Fig. 4D). The decrease of these proteins was in
line with the RNAseq data. Reciprocally, RNAseq had
revealed the increase of mRNAs for transcription factors
normally expressed in the trunk like Hox genes, and/or
caudally to the forebrain in the mid/hindbrain, such as
Gbx1, Gbx2, En1, Foxb1, Foxd3 and Hes3. Actually, the
Hox5 protein was detected in the atrophied lateral ven-
tricles of E13.5 mutants, namely more rostrally than the
normal anterior limit of Hox genes (Fig. 4E), and Gbx1
also was shifted rostrally in the telencephalon of E10.5
mutants compared to its normal expression caudal to
hindbrain rhombomere 2 in control embryos (Fig. 4F).
Cell interactions also contribute to the morphological
defects caused by ectopic CDX2, as exemplified in eye
remnants (Fig. 5A). In a few E12.5 mutants, rudimentary
ocular structures developed when the tip of the optic stalk
Fig. 2 Gene modulation caused by rostral ectopic expression of CDX2. A Principal Component Analysis of the 532 differentially expressed genes
by rostral ectopic expression of CDX2 in the head of E10.5 embryos (absolute Log2FC > 0.4, adjp < 0.05). B Functional Annotation Clustering
(Enrichment score > 3; p < 0.01) of the 3 gene categories defined by Principal Component Analysis. pvalues were corrected with FDR multiple testing
method. C Venn representation of the genes upregulated by ectopic expression of CDX2 in the head (green), of those upregulated in embryonic
stem cells treated with CHIR99021 plus Fgf8 (brown), and of those downregulated in Cdx-null embryos (blue). D GO term representation (Enrichment
score > 3; p < 0.01) for the lists of common genes displayed by the comparative analysis in D
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remained CDX2-free. The neuroepithelium differentiated
into a layer of Otx2-positive retinal pigment cells but
failed to invaginate into optical cuff and to form the Sox2-
positive neural layer. Concomitantly, the surface ecto-
dermal layer facing the Otx2-positive neuroepithelium,
also ectopically expressing CDX2, did not invaginate into
the lens while maintaining p63 in contrast to its normal
loss in the presumptive lens ectoderm26. Thus, ectopic
CDX2 not only perturbs neuroepithelium development,
but it also alters neuroepithelial-ectodermal interactions
needed for eye morphogenesis.
Together with forebrain alterations, RsCDX2::Sox2-
CreERT2 mutants exhibited strong defects in the fronto-
nasal process. The rostral shift in Hox expression
corroborated the incompatibility of these genes with
craniofacial development27–29. While the frontonasal
process develops from the colonization of streams of
diencephalic and anterior mesencephalic neural crest cells
around E8.5-E9.53, RNAseq data revealed mRNA changes
for members of genes families involved in cell guidance
during neural crest cell migration including Erbb3/4,
Sema3b/6b, Nrp1/2 and Epha2/a3/a5/b1. Sox10 immu-
nostaining used to label cells of neural crest origin showed
a reduction of cell number in E10.5 mutants compared to
controls, accompanied by cleaved-Caspase-3 staining and
a low rate of phospho-Histone-3-positive cells (Fig. 5B).
Thus, ectopic CDX2 compromises the migration and
survival of neural crest cells intended to form the face. In
addition, in absence of frontonasal process, the rostral-
most wall of the forebrain was profoundly remodeled, as
illustrated at E13.5 (Fig. 6A). The resulting structure was
made of a compact, yet vascularized, cell mass covered by
a single-layered CDX2-free but p63- and Sox9-positive
epithelium. The cell mass strongly expressed CDX2, was
proliferative, but devoid of all neuroepithelial factors
tested here (Foxg1, Gbx1, Nkx2.1, Otx2, Six3, Sox2, Sox9)
and also Sox10, suggesting no neural crest cell origin.
Earlier stages at E11.5-E12.5 revealed the dynamics of the
Fig. 3 Homeobox gene changes caused by the ectopic expression of CDX2. A Enrichment analysis (p < 0.01) in DNA binding sites present in the
−2000/+ 50-bp promoters of the 532 differentially-expressed genes. B Expression of the Hox clusters genes in control (black boxes) and mutant
(gray boxes) E10.5 littermates. Ca CDX2 chromatin immunoprecipitation of Hoxa5 promoter DNA in the trunk (lanes 1) and head (lanes 2) of an E10.5
control embryo and in the head of a mutant littermate (lanes 3). b Quantification by qPCR of the chromatin immunoprecipitation of Hoxa5 promoter
DNA in the trunk (lanes 1) and head (lanes 2) of an E10.5 control embryos and in the head of mutant littermates (lanes 3) (n= 3). The results are
expressed relative to the value fixed at 1 in the trunk of the controls
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process where the Otx2-positive neuroepithelium
expressing CDX2 became patchy and progressively
replaced by CDX2-positive and Otx2-negative cells (Fig.
6B). This replacement was associated with the release of
cellular material from the neuroepithelium into the tele-
ncephalic ventricles (Fig. 6C), without evidence of
cleaved-Caspase-3 apoptosis. Thus, ectopic expression of
CDX2 compromises the development of the facial neural
crest-derived mesenchyme, associated with the disin-
tegration of the neuroepithelium and its replacement by
cells having lost neuroepithelial properties.
Discussion
Although the impact of the loss of CDX function during
embryonic development has been well documented,
deciphering the primary role of this gene family in trunk
elongation and patterning8,30, the effect of the abnormal
anterior gain of function has not been studied so far in
vertebrates. In D. melanogaster, forced expression of the
caudal orthologue in the anterior pole at the syncytial
embryonic stage induces head malformations, yet without
homeotic changes31. Here, we developed the model of
ectopic expression of CDX2 in rostral tissues of mouse
Fig. 4 Histology and transcription factor alterations by rostral ectopic expression of CDX2. A Histology and CDX2 immunostaining in
parasagittal sections of E10.5 control and mutant littermates. Asterisks show forebrain vesicles and arrowheads the endogenous Cdx2 protein in the
gut endoderm. Bars: 1 mm. B Same as A for transversal head sections of E13.5 control and mutant littermates. Bars: 1 mm. C Transcription factor
immunodetection in parasagittal head sections of E10.5 control and mutant littermates. Asterisks: telencephalic vesicles. Bars: 200 µm. D Same as C in
transversal head sections of E13.5 control and mutant embryos. Bars: 100 µm. E Same as D. Bars: 100 µm. F Same as C. Bars: 50 µm
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embryos to investigate the consequences of disturbing the
balance between the anterior and posterior ontogenetic
programs. The resulting embryos present with huge brain
and craniofacial dysgenesis recapitulating several aspects
of human malformations including holoprosencephaly.
These malformations are associated with the decrease of
important genes of the anterior program together with the
rostral onset of elements of the posterior program among
which are the trunk Hox genes. Unlike the endoderm,
where ectopic CDX2 induces a homeotic shift from
foregut to midgut-like properties32, in the rostral neu-
roepithelium this factor leads to missing head structures
associated with perturbations in cell movement, pro-
liferation and death, in particular at the level of neural
crest cells and for the formation of eyes. This likely results
from the interference between the endogenous anterior
program of the head and the ectopic posterior program
driven by the CDX2 protein known from gut studies to be
a regulator of active chromatin organization33,34.
This work is highly relevant as regards head dysgenesis
diseases in humans because a number of cases, among
which the Patau syndrome, are associated with copy
number amplification of the chromosome 13 locus over-
lapping CDX2. Thus, this study highlights that, in addition
to single gene mutations in the head ontogenetic pro-
gram2, the imbalance between head and trunk programs
around gastrulation could be a novel basis of head dys-
genesis. The mouse phenotype resulting from the forced
expression of CDX2 anteriorly above the normal anterior-
posterior gradient, recapitulates observations made in
human, including not only brain malformations, eye
defects and frontonasal dysmorphology but also forelimb
polydactyly. Together, these data open the way to further
fetopathological studies to address in humans the
importance of the imbalance between the anterior and
posterior ontogenetic programs in head dysgenesis dis-
eases of still unknown origin.
Material and methods
Mice and treatments
All the mouse experiments were performed in the cer-
tified animal facility (number H-67-482-21) according to
Fig. 5 Eye and frontonasal malformations caused by rostral ectopic expression of CDX2. A Serial transversal sections of eyes and ocular
remnants of E12.5 control and mutant littermates. Inserts are higher magnification of the retinal pigment epithelium and of the p63-positive
ectodermal epithelium. Black and open arrowheads show retinal pigment cell layer and ectodermal layer, respectively. Bars: 100 µm. B Serial
parasagittal sections of the frontonasal process (arrowheads) of E10.5 control and mutant littermates. Asterisks: telencephalic ventricles. Bars: 200 µm
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the protocol approved by the French Ministry of Agri-
culture under the permit APAFiS#833.
The RsCDX2 mouse was generated by inserting into the
Rosa26 locus the cassette made of a Splicing Acceptor
site, an excisable fragment flanked by loxP sites and the
FLAG-tagged form of the human CDX2 cDNA35. The
excisable fragment contains the transcription unit formed
by the pgk1 promoter, the neomycin-resistance coding
sequence and the Growth Hormone polyadenylation site.
The RsCDX2 mouse was generated at the Mouse Clinic
Institute (Illkirch, France). A schematic representation of
the RsCDX2 allele is shown in Fig. 1Aa.
Sox2CreERT2 (stock number 017593)36 and Rosa-
CAGtdTomato (stock number 007909)37 mice were from the
Jackson laboratory. Tail DNA and extraembryonic
membrane DNA were respectively used for genotyping
adult mice and embryos by PCR with the following pri-
mers: RsCDX2 allele: GTGGTTTGTCCAAACTCATCA/
CACGTGGTAACCGCCGTAGTC; Sox2CreERT2 allele:
GCGGTCTGGCAGTAAAAACTATC/GTGAAACAG
CATTGCTGTCACTT; RosaCAGtdTomato allele: GGCAT
TAAAGCAGCGTATCC/CTGTTCCTGTACGGCAT
GG.
Pregnant females of RsCDX2::Sox2CreERT2 or Rosa-
CAGtdTomato::Sox2CreERT2 intercrosses were given a single
intraperitoneal injection of 2 mg of Tamoxifen in corn oil
at day 6 after vaginal plug detection (E6.5 post coitum).
In all the figures illustrated for this work, control (ctrl)
and mutant (RsCDX2::Sox2CreERT2) embryos were litter-
mates; the controls were either wild-type or RsCDX2 or
Sox2CreERT2 embryos, giving identical results. Littermates
with no detectable head expression of ectopic CDX2 pro-
tein by immunohistochemistry were excluded. For each
developmental stage, embryos from 3 littermates with
ectopic CDX2 expression were analyzed. No randomization
was used. Phenotypic analyses were performed in blind.
Fig. 6 Progressive changes of the anterior-most wall of the forebrain by rostral ectopic expression of CDX2. A Serial transversal sections of
the anterior-most wall (arrowheads) of the telencephalon (asterisks) in an E13.5 mutant embryo. Bars: 100 µm. B Serial transversal sections of an E12.5
mutant embryo and serial parasagittal sections of an E11.5 mutant embryo. Open arrowheads show cell delamination and cell debris from the
neuroepithelium into the telencephalic ventricles. Bars: 100 µm. C Higher magnification of cell debris (open arrowheads) released in the telencephalic
ventricles (asterisks) of E11.5 and E12.5 mutant embryos. Bars: 50 µm
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Histology and immunohistochemistry
Whole-mount immunohistochemistry was performed
on E9.5 embryos as described38. For this purpose,
embryos were fixed overnight in DMSO/methanol (1:4),
rehydrated in PBS, blocked in 2% dry milk, 0.5% Triton
X100 and incubated overnight with rabbit anti-CDX2
antibody CDX2 (Abcam; ab76541; RRID:AB_1523334,
dilution 1:5000). HRP-labeled goat anti-rabbit antibody
(Vector Laboratories; PI-1000; RRID: AB_2336198, dilu-
tion 1:500) was added overnight and revealed with DAB.
Embryos were cleared with Methyl Salicylate before
observation.
For immunohistochemistry on tissue sections, E10.5 to
E15.5 embryos were fixed with 4% PFA, embedded in
paraffin and sectioned (5 µm) before staining with
hematoxylin-eosin (HE) or by immunohistochemistry, as
described39. Antibodies were: rabbit anti-cleaved-
Caspase-3 (R&D System; AF835; RRID:AB_2243952,
dilution 1:500), rabbit anti-CDX2 (Abcam; ab76541;
RRID:AB_1523334, dilution 1:10,000), rabbit anti-Foxg1
(Abcam; ab18259; RRID:AB_732415, dilution 1:1000),
rabbit anti-Gbx1 (dilution 1:5000)40, mouse anti-Hoxa5
(Santa Cruz; sc-515309, dilution 1:250), mouse
anti-Nkx2.1 (Thermo Fischer; MA5-13961; RRID:
AB_10984070, dilution 1:500), rabbit anti-Otx2 (Abcam;
ab183951, dilution 1:250), rabbit anti-p63 (Abcam;
ab124762; RRID:AB_10971840, dilution 1:2000), rabbit
anti-phospho-Histone-3 (Millipore; 06-570; RRID:
AB_310177, dilution 1:1000), guinea pig anti-Six3
(Rockland; 200-201-A26S; RRID:AB_1961548, dilution
1:1000), mouse anti-Sox2 (R&D System; MAB2018; RRID:
AB_358009, dilution 1:500), rabbit anti-Sox9 (dilution
1:500)41, rabbit anti-Sox10 (Sigma-Aldrich; Ab383R,
dilution 1:350). Secondary biotinylated antibodies were
from Vector Laboratories and used at the dilution 1:200:
goat anti-guinea pig (BA-7000; RRID:AB_2336132), goat
anti-rabbit (BA-1000; RRID: AB_2313606), rabbit anti-
goat (BA-5000; AB_2336126), goat anti-mouse (BA-9200;
RRID:AB_2336171).
RNA extraction, RTqPCR and RNAseq analyses
RNA was individually prepared using TRI Reagent
(Euromedex, France) from each of 3 control and 3 mutant
E10.5 littermate embryos sectioned to separate the head
(sectioned under the binocular loop between the max-
illary and mandibular components of the pharyngeal arch
1), the trunk and the tail. Total RNA was treated with
DNAse (RQ1 RNAse-free DNAse, Promega Inc.) and its
quality was assessed with a Bioanalyzer (Agilent).
For RTqPCR, reverse transcription was performed with
2 µg RNA using SuperScript II Reverse Transcriptase
(Invitrogen) and Oligo(dT)12-18 primer (Invitrogen).
Quantification of the endogenous Cdx2 transcript and of
the transcript of the CDX2 transgene was performed
using the TaqMan Master Mix and gene-specific TaqMan
primers sets (TaqMan Gene Expression assays, Life
Technologies Applied Biosystems): mouse Cdx2,
Mm01212280_m1; human CDX2, Hs00230919_m1, and
mouse Tbp, Mm00446973_m1. Analysis of the results
obtained in triplicate was performed with the 7500 soft-
ware v2.0.1 (Life Technologies Applied Biosystems) using
the relative ΔΔCt quantification method.
For RNAseq, 1 µg of total RNA of each preparation
made from the head of 3 control and 3 mutant embryos
was used to prepare the sequencing libraries using the
Illumina TruSeq stranded mRNA kit, following the sup-
plier’s recommendations. The quality and the quantity of
the libraries were both assessed on a High Sensitivity chip
with a Bioanalyzer. The libraries were diluted to 10 pM to
generate clusters in both lanes of a Rapid flowcell (Illu-
mina). Sequencing was performed with a HiSeq1500
(Illumina) in paired-end for a read length of 50b. Cluster
mapping was done with the software RTA (v1.13 Illu-
mina). The base calling and the demultiplexing were
performed with the software bcl2fastq (v2.17.1.14
Illumina).
The quality of the sequencing reads was assessed with
FASTX-toolkit (v0.0.13) and no pre-processing was nee-
ded. The alignment of the reads was done with STAR
v2.542 against the reference genome of Mus musculus
(GRCm38.90). To assess its expression, the human
transgene hCDX2 (ENSG00000165556) was added to the
reference murine genome as an additional gene and
processed as the canonical ones. The aligner STAR was
used with default parameters and the alignment was
refined with a second pass. The read counting was done
with HTSeq v0.6.143 in union mode and at gene level. The
normalization of gene expression as well as the con-
sistency among biological replicates were both assessed
with the R package DESeq2 1.10.144. Differential expres-
sion analysis was also done with DESeq2. Prior to the
Wald test, the values of log2(Fold Change) were not
shrunk. The significantly differentially-expressed genes
were identified based on the p-value, corrected with the
False Discovery Rate (FDR) multiple testing method, and
the log2(Fold Change). Genes with an absolute log2(Fold
Change) ≥ 0.4 and an adjusted p-value < 0.05 were con-
sidered as differentially expressed. All the downstream
analyses were done with R and with DAVID45; Gene
Ontology enrichment was done with the one-tailed exact
Fisher test and the pvalues were corrected with FDR
multiple testing method.
The transcription factor binding motifs in the pro-
moters (from 2000-bp upstream to 50-bp downstream of
the transcription starting site) of the differentially
expressed genes were analyzed with the software HOMER
v4.1046. Only the known and curated motifs were used for
the enrichment analysis. The enriched motifs were
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manually curated comparing with the most up-to-date
version of JASPAR47 and Tomtom from the MEME
software suite48.
Chromatin immunoprecipitation
E10.5 embryos were harvested and sectioned under the
binocular loop between the maxillary and mandibular
components of the pharyngeal arch 1, and above the
posterior limbs, to collect and freeze separately in liquid
nitrogen the head and the trunk segments, respectively.
Extraembryonic membranes were used for genotyping the
embryos.
Chromatin immunoprecipitation (ChIP) assay was per-
formed on the head and trunk segments of single control
and mutant littermate embryos, using the ChIP IT High
Sensitivity Kit (Active Motif), accordingly to the supplier’s
recommendations. Volumes and durations of reactions
were adapted to the weak amount of tissue recovered at
this stage (5-20 mg tissue per sample). Briefly, embryonic
tissues were fixed in 1% PFA then sonicated. Chromatin
was incubated overnight with 2 µg of rabbit anti-CDX2
(Abcam; ab76541; RRID:AB_1523334). The antibody-
bound protein/DNA complexes were precipitated using
protein G agarose beads. After DNA purification on the
DNA purification column, PCR reactions were performed
on input and immunoprecipitated DNA for 38 cycles
using primers flanking the Cdx2-binding site within the
HoxA5 promoter: CGCTTTAACCCCTTTCAATTAC/
GCTAGGCCCAACCCTGTTAG15, or as negative con-
trol with primers corresponding to a genomic segment of
the second intron of the Cdx2 gene, devoid of Cdx2
binding site: TGGGGCAATCTTAATGGGTA/
TGTAGCCTTGACTTGGCTTT19. Quantification of the
ChIP was performed by Sybr Green qPCR with the above
HoxA5 primers and the FastStart Universal SYBR Green
Master kit (Roche), using the ΔΔCt method relative to the
Input and fixed at 1 for the value obtained in the samples
of the trunk.
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